Skip to main content

Advertisement

SpringerLink
Log in

Influenza virus infection: an approach to identify predictors for in-hospital and 90-day mortality from patients in Vienna during the season 2017/18

  • Original Paper
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Background

Seasonal influenza outbreaks are associated with increased mortality and hospitalisation rates. Herein we tried to identify predictors of mortality in hospitalised patients with influenza virus infection.

Materials/methods

In this exploratory retrospective observational single-centre-study we included all influenza-positive patients older than 18 years who were hospitalised and treated at the flu-isolation-ward during the influenza season 2017/18. Diagnosis was based on point-of-care-test with the Alere™ i. First we performed χ2 tests and Mann–Whitney U tests to identify predictors of mortality. Significant variables were used in a stepwise-forward-logistic-regression-model to predict in-hospital and 90-day mortality.

Results

Of the 396 patients who tested positive for influenza 96 (24.2%) had influenza A and 300 (75.8%) influenza B. Twenty-two (5.6%) died in hospital and the 90-day mortality rate was 9.4%. In the stepwise logistic regression older age (OR 1.1 per year 95% CI 1.03–1.17), history of atrial fibrillation (OR 5.91 95% CI 1.91–18.34), dementia (OR 3.98 95% CI 1.24–12.78), leucocyte count (OR 1.11 per G/L 95% CI 1.03–1.20), pneumonia (OR 4.39 95% CI 1.44–13.39) and acute heart failure (OR 23.15 95% CI 4.33–123.76) increased the risk of in-hospital mortality. The risk for 90-day mortality was increased by older age (OR 1.04 per year 95% CI 1.01–1.07), history of atrial fibrillation (OR 3.1, 95% CI 1.36–7.05), history of congestive heart failure (OR 4.7 95% CI 1.94–11.48), pneumonia (OR 3.2 95% CI 1.45–6.91) and decreased by statin use (OR 0.28 95% CI 0.10–0.78).

Conclusions

Older age, history of atrial fibrillation and pneumonia are associated with increased risk of influenza-associated in-hospital and 90-day mortality. Statin use may decrease 90-day mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Girard M, Cherian T, Pervikov Y, et al. A review of vaccine research and development: human acute respiratory infections. Vaccine. 2005;23:5708–24.

    Article  CAS  Google Scholar 

  2. Haviari S, Bénet T, Saadatian-Elahi M, et al. Vaccination of healthcare workers: a review. Hum Vaccines Immunother. 2015;11:2522–37.

    Article  Google Scholar 

  3. Paules CI, Sullivan SG, Subbarao K, et al. Chasing seasonal influenza—the need for a universal influenza vaccine. N Engl J Med. 2018;378:7–9.

    Article  Google Scholar 

  4. Lee N, Choi KW, Chan PKS, et al. Outcomes of adults hospitalised with severe influenza. Thorax. 2010;65:510–5.

    Article  CAS  Google Scholar 

  5. Chung JY, Hsu CC, Chen JH, et al. Geriatric influenza death (GID) score: a new tool for predicting mortality in older people with influenza in the emergency department. Sci Rep. 2018;8:9312. https://doi.org/10.1038/s41598-018-27694-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chaves SS, Aragon D, Bennett N, et al. Patients hospitalized with laboratory-confirmed influenza during the 2010–2011 influenza season: exploring disease severity by virus type and subtype. J Infect Dis. 2013;208:1305–14.

    Article  Google Scholar 

  7. Chagvardieff A, Persico N, Marmillot C, et al. Prospective comparative study of characteristics associated with influenza A and B in adults. Médecine et Maladies Infectieuses. 2017;48:180–7.

    Article  Google Scholar 

  8. Topoulos S, Giesa C, Gatermann S, et al. Analysis of acute respiratory infections due to influenza A, B and RSV during an influenza epidemic 2018. Infection. 2019. https://doi.org/10.1007/s15010-018-1262-x.

    Article  PubMed  Google Scholar 

  9. Simonsen L, Clarke MJ, Williamson GD, et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87:1944–50.

    Article  CAS  Google Scholar 

  10. Govaert TM, Dinant GJ, Aretz K, et al. The predictive value of influenza symptomatology in elderly people. Fam Pract. 1998;15:16–22.

    Article  CAS  Google Scholar 

  11. Monto AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243–7.

    Article  CAS  Google Scholar 

  12. Vanhems P, Benet T, Munier-Marion E. Nosocomial influenza: encouraging insights and future challenges. Curr Opin Infect Dis. 2016;29:366–72.

    Article  Google Scholar 

  13. Trabattoni E, Le V, Pilmis B, et al. Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an emergency department. Am J Emerg Med. 2018;36:916–921.

    Article  CAS  Google Scholar 

  14. Andrews D, Chetty Y, Cooper BS, et al. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use. BMC Infect Dis. 2017;17:671.

    Article  Google Scholar 

  15. Cate TR. Clinical manifestations and consequences of influenza. Am J Med. 1987;82:15–9.

    Article  CAS  Google Scholar 

  16. Monmany J, Rabella N, Margall N, et al. Unmasking influenza virus infection in patients attended to in the emergency department. Infection. 2004;32:89–97.

    Article  CAS  Google Scholar 

  17. Casalino E, Antoniol S, Fidouh N, et al. Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: a 3-year prospective observational study during seasonal epidemic periods. PLoS One. 2017;12:e0182191.

    Article  Google Scholar 

  18. Musher DM, Abers MS, Corrales-Medina VF, et al. Acute infection and myocardial infarction. N Engl J Med. 2019;380:171–6.

    Article  CAS  Google Scholar 

  19. Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2010;347:f5061.

    Article  Google Scholar 

  20. Bell J, Bonner A, Cohen DM, et al. Multicenter clinical evaluation of the novel Alere I Influenza A&B isothermal nucleic acid amplification test. J Clin Virol. 2014;61:81–6.

    Article  CAS  Google Scholar 

  21. Hurtado JC, Mosquera MM, de Lazzari E, et al. Evaluation of a new, rapid, simple test for the detection of influenza virus. BMC Infect Dis. 2015;15:44.

    Article  Google Scholar 

  22. Van Nguyen JC, Camelena F, Dahoun M, et al. (2016): prospective evaluation of the Alere I Influenza A&B nucleic acid amplification versus Xpert Flu/RSV. Diagn Microbiol Infect Dis. 2016;85:19–22.

    Article  Google Scholar 

  23. Nie S, Roth RB, Stiles J, et al. Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and B. J Clin Microbiol. 2014;52:3339–44.

    Article  CAS  Google Scholar 

  24. Garcia-Ptacek S, Farahmand B, Kareholt I, et al. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia registry. J Alzheimers Dis. 2014;41:467–77.

    Article  Google Scholar 

  25. Liao KM, Lin TC, Yang YH. Dementia increases severe sepsis and mortality in hospitalized patients with chronic obstructive pulmonary disease. Medicine (Baltimore). 2015;94:e967.

    Article  Google Scholar 

  26. Schnaider-Beeri M, Goldbourt U. Late-life dementia predicts mortality beyond established midlife risk factors. Am J Geriatr Psychiatry. 2011;19:79–87.

    Article  Google Scholar 

  27. Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378:345–53.

    Article  Google Scholar 

  28. Irving SA, Patel DC, Kieke BA, et al. Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004–2005 through 2007–2008. Influenza Other Respir Viruses. 2011;6:37–43.

    Article  Google Scholar 

  29. Belongia EA, Irving SA, Waring SC, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008–2009 (H1N1), and 2007–2008 (H3N2) infections. JAMA. 2010;304:1091.

    Article  CAS  Google Scholar 

  30. Vandermeer ML, Thomas AR, Kamimoto L, et al. Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis. 2012;205:13–9.

    Article  CAS  Google Scholar 

  31. Kwong JC, Li P, Redelmeier DA. Influenza morbidity and mortality in elderly patients receiving statins: a cohort study. PLoS One. 2009;4:e8087.

    Article  Google Scholar 

  32. Brassard P, Wu JW, Ernst P, et al. The effect of statins on influenza-like illness morbidity and mortality. Pharmacoepidemiol Drug Saf. 2016;26:63–70.

    Article  Google Scholar 

  33. https://www.virologie.meduniwien.ac.at/wissenschaft-forschung/virus-epidemiologie/influenza-projekt-diagnostisches-influenzanetzwerk-oesterreich-dinoe/vorhergehende-saisonen/saison-20172018/. Accessed 8 Apr 2019.

  34. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–82.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department for Infectious Diseases, Kaiser-Franz-Josef-Hospital (KFJ), Kundratstraße 3, 1100, Vienna, Austria

    E. Pawelka, Mario Karolyi, H. Laferl, I. Niculescu, A. Zoufaly & C. Wenisch

  2. Medical University Vienna (MUW), Spitalgasse 23, 1090, Vienna, Austria

    S. Daller, C. Kaczmarek, B. Schrader & C. Stütz

Authors
  1. E. Pawelka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Karolyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Daller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Kaczmarek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Laferl
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. Niculescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Schrader
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Stütz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Zoufaly
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Wenisch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario Karolyi.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pawelka, E., Karolyi, M., Daller, S. et al. Influenza virus infection: an approach to identify predictors for in-hospital and 90-day mortality from patients in Vienna during the season 2017/18. Infection 48, 51–56 (2020). https://doi.org/10.1007/s15010-019-01335-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-019-01335-0

Keywords

Search

Navigation